Health
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS – GlobeNewswire
Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS,…
- Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative dise…
Continue Reading
-
General14 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News13 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
Noosa News24 hours agoMenulog announces shock closure in Australia after ‘challenging circumstances’
-
Noosa News16 hours agoMirvac to sell site to Irvine Group
